Investor Complaints: Contrafect Corporation (NASDAQ: CRFX)

The securities and investment fraud law firm Fitapelli Kurta is interested in speaking to investors who have lost money investing in Contrafect Corporation (NASDAQ: CRFX).

According to MarketWatch, Contrafect Corp. is a biotechnology company focused on developing and commercializing protein and antibody products for lethal bacterial and viral diseases. It trades on  the NASDAQ exchange under CRFX.

Contrafect is particularly focused on drug-resistant infections acquired in hospitals, which it notes are “currently the fourth leading cause of death in the United States.” Contrafect’s current product candidates include “lysin and monoclonal antibody platforms” that target regions in viruses and bacteria that are not likely to mutate, and new agents to combat antibiotic-resistant forms of staph infection and influenza.

Dr. Steven C. Gilman has served as Executive Chairman of Contrafect Corp. since 2015; Julia P. Gregory has served as Chief Executive Officer and Director since 2012; Michael Wittekind has served as Chief Science Officer and Senior Vice President since 2012; Daniel Couto has served as Senior Vice President, Product Development since 2011. Michael Messinger serves as Chief Accounting Officer and Vice President, Finance.

In June 2015 Contrafect Corp. announced a $20,000,000 private placement led by a group of institutional investors including Oracle Investment Management, Broadfin Capital, Birchview Capital, and Cormorant Asset Management. The placement consisted of about 4.73 million shares of common stock, as well as warrants to purchase about 2.36 million shares of common stock. According to Contrafect’s CEO, Julia Gregory, the proceeds from the private placement would help to fund Contrafect’s Phase 2 clinical trials two pharmaceutical products.

Contrafect Corporation (CRFX) was recently offered by Maxim Group, LLC.

If you have lost money investing in Contrafect Corporation (CRFX), call the securities and investment fraud law firm Fitapelli Kurta at 877-238-4175 for a free consultation. You may be qualified to recover your losses. All cases are taken on contingency: we only get paid if and when you recover money.  Time to file your claim may be limited, so we encourage you to avoid delay. Call 877-238-4175 now to speak to an attorney for free.